MrgD as a Novel Modeling and Treatment Target for Pulmonary Hypertension
MrgD deficiency in pulmonary arterioles increases susceptibility to PH, particularly in a hypoxic environment. MrgD is a potential modeling and therapeutic target for PH.
Authors
- Lina Yao (ORCID: https://orcid.org/0000-0003-1018-5646)
- Panpan Hao (ORCID: https://orcid.org/0000-0001-6903-1233)
- Qimou Li (ORCID: https://orcid.org/0000-0003-2998-7454)
- Huaying An
- Hongyu Zhong (ORCID: https://orcid.org/0009-0008-0536-0642)
- Cong Fan (ORCID: https://orcid.org/0000-0001-5668-6361)
- Qianqian Wang (ORCID: https://orcid.org/0000-0002-6942-1298)
- Yun Zhang (ORCID: https://orcid.org/0000-0003-4432-6144)
- Xiaolin Liu (ORCID: https://orcid.org/0000-0001-6517-4165)
- Mei Zhang (ORCID: https://orcid.org/0000-0001-6295-5070)
- Cheng Zhang (ORCID: https://orcid.org/0000-0003-3672-6543)
- Lijun Fang (ORCID: https://orcid.org/0000-0001-8590-3994)
- Dongdong Liu (ORCID: https://orcid.org/0000-0002-0641-9975)
Institutions
- Qingdao University (CN)
- Affiliated Hospital of Qingdao University (CN)
- Qilu Hospital of Shandong University (CN)
Publication Details
- Journal
- Arteriosclerosis Thrombosis and Vascular Biology
- Published
- 2025-03-27
- DOI
- https://doi.org/10.1161/atvbaha.124.322337
- Citations
- 4
- Primary Topic
- Pulmonary Hypertension Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 6.07